MIA2 activators constitute a class of chemicals that can influence the protein MIA2 by modulating specific cellular pathways and processes, even though direct activators may not be conclusively identified. These chemicals encompass a diverse range of compounds, each with its own distinct mechanism of action. For instance, retinoic acid (RA) has been associated with the regulation of melanocyte development and differentiation pathways. MIA2, being linked to melanoma, can be indirectly affected by RA as it modulates these melanocyte-specific pathways, leading to changes in MIA2 expression or activity within melanoma cells. Additionally, forskolin, through its ability to elevate intracellular cAMP levels, has the to influence signaling pathways associated with MIA2. While the precise connections between forskolin and MIA2 remain undefined, changes in cAMP levels can impact downstream signaling cascades that might intersect with MIA2 regulation, affecting its cellular functions.
Furthermore, chemicals such as phorbol esters (e.g., PMA) activate protein kinase C (PKC) and numerous cellular pathways, some of which may be relevant to melanoma and MIA2. By initiating PKC-mediated signaling cascades, phorbol esters can indirectly influence MIA2 in melanoma cells. Similarly, SAG (Smoothened Agonist) is a compound that modulates the Hedgehog signaling pathway. Although the direct connection between MIA2 and Hedgehog signaling remains uncertain, the influence of SAG on Hedgehog-related processes can indirectly impact MIA2.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Influences melanocyte development and differentiation pathways, potentially impacting MIA2 in melanoma. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels, which can indirectly affect MIA2 by modulating downstream signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC and diverse cellular pathways, potentially influencing MIA2 via PKC-mediated signaling. | ||||||
SAG | 912545-86-9 | sc-212905 sc-212905A | 1 mg 5 mg | $166.00 $421.00 | 27 | |
Modulates Hedgehog signaling, potentially affecting MIA2 through Hedgehog-related processes. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits TGF-β receptor, indirectly impacting MIA2 through potential crosstalk with TGF-β pathways. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Modulates adipocyte differentiation pathways, potentially influencing MIA2 in adipose tissue and melanoma. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
Modulates Wnt signaling, potentially affecting MIA2 indirectly through crosstalk with other pathways. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Modulates the Notch pathway, potentially influencing MIA2 through pathway interactions. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $82.00 $158.00 | 1 | |
Inhibits smoothened in Hedgehog signaling, potentially indirectly affecting MIA2 in melanoma. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NF-κB pathway, potentially impacting MIA2-related gene expression in melanoma. | ||||||